<DOC>
	<DOCNO>NCT00731601</DOCNO>
	<brief_summary>A large dose PPI effective preventing peptic ulcer rebleeding . The investigator hypothesize 40 mg/q6h pantoloc equivalent 8mg/h pantoloc prevent rebleeding .</brief_summary>
	<brief_title>Intravenous Proton Pump Inhibitor Peptic Ulcer Bleeding</brief_title>
	<detailed_description>A bleeding peptic ulcer remain serious medical problem significant morbidity mortality . Endoscopic therapy significantly reduce bleeding , surgery , mortality patient bleed peptic ulcer recommend first hemostatic modality patient . In past year , adjuvant use high-dose proton pump inhibitor ( PPI ) endoscopic therapy endorsed study , two consensus statement two meta-analysis . In previous experience , use omeprazole 160 mg /day infusion instead 8 mg/h patient obtain good result . The objective study assess outcomes two different regimen high dose intravenous pantoprazole endoscopic therapy patient peptic ulcer bleeding .</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Peptic Ulcer</mesh_term>
	<mesh_term>Peptic Ulcer Hemorrhage</mesh_term>
	<mesh_term>Proton Pump Inhibitors</mesh_term>
	<mesh_term>Pantoprazole</mesh_term>
	<criteria>Patients accept endoscopic therapy peptic ulcer active bleeding , nonbleeding visible vessel ( NBVV ) adherent blood clot ulcer base observe within 24 hour hospital admission . If patient pregnant Did obtain initial hemostasis endoscopic injection epinephrine Did give write informed consent Had bleeding tendency ( platelet count &lt; 50Ã—109/L , serum prothrombin &lt; 30 % normal , take anticoagulant ) , uremia .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>shock</keyword>
	<keyword>peptic ulcer bleeding</keyword>
	<keyword>rebleeding</keyword>
</DOC>